Targeted therapy against CYP genetic polymorphism can be an important addition to optimal cancer therapy [33]. The optimal cancer therapy should involve multimodal and multi-targeted therapies including targeted therapy against CYP 450 polymorphisms for better malignancy management and CYP genetic polymorphisms can modulate the risk even in oral cancer [34]. Here, PPIG is linked to cancer.